Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Stanford Cancer Center

875 Blake Wilbur Drive     
Palo Alto , CA 94304
USA

 

Principal Investigator:
Contact:
General Questions: (650) 498-7425 clinicaltrials@med.stanford.edu Cancer Clinical Trials: (650) 498-7061 Institutional Review Board: (866) 680-2906
Activation Status of this Site:
Active
Notes about this Site:
Stanford Cancer Center Website:
http://med.stanford.edu/clinicaltrials/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.